Alder BioPharmaceuticals Inc (ALDR)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

11804 NORTH CREEK PARKWAY SOUTH BOTHELL, WA 98011

Alder Biopharmaceuticals, Inc. provides pharmaceutical products and services. The Company offers identifies, develops, and manufactures antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular, and autoimmune and inflammatory disease areas. Alder Biopharmaceuticals operates in the United States.

View SEC Filings from ALDR instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ALDR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALDR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SMITH JEFFREY T L MANAGING DIRECTOR

  • Officer
0 2019-10-22 1

PRESTON HEATHER

  • Director
0 2019-10-22 1

MONTGOMERY ALAN BRUCE

  • Director
0 2019-10-22 1

SIEGALL CLAY B

  • Director
0 2019-10-22 1

HASSLER RANDAL EVP, PHARMACEUTICAL OPS.

  • Officer
0 2019-10-22 1

CLEVELAND PAUL B

  • Director
0 2019-10-22 1

CARTER PAUL RUTHERFORD

  • Director
0 2019-10-22 1

BUCHER JAMES B EVP & GENERAL COUNSEL

  • Officer
0 2019-10-22 1

YARNO WENDY L

  • Director
0 2019-10-22 1

LAVELLE ERIN CHIEF OPERATING OFFICER

  • Officer
0 2019-10-22 1

REDMILE GROUP, LLC

GREEN JEREMY

  • Director
0 2019-10-22 1

AZELBY ROBERT PRESIDENT AND CEO

  • Officer
  • Director
0 2019-10-22 1

CAMPOY CARLOS CHIEF FINANCIAL OFFICER

  • Officer
0 2019-10-22 1

STRECK PAUL CHIEF MEDICAL OFFICER

  • Officer
0 2019-10-22 1

DAC NADIA CHIEF COMMERCIAL OFFICER

  • Officer
0 2019-10-22 1

H LUNDBECK A S

  • 10% Owner
0 2019-10-22 1

BENEDICT LARRY EVP AND PAO

  • Officer
39,728 2019-04-23 0

LATHAM JOHN A CHIEF SCIENTIFIC OFFICER

  • Officer
244,180 2019-02-06 0

LITTON MARK JAMES CHIEF BUSINESS OFFICER

  • Officer
180,189 2018-06-01 0

PAKIANATHAN DEEPIKA

  • Director
0 2018-05-23 0

CARTER ERIC G INTERIM CHIEF MEDICAL OFFICER

  • Officer
0 2018-04-23 0

SCHATZMAN RANDALL C PRESIDENT AND CEO

  • Officer
  • Director
0 2018-02-16 0

SANDOVAL ELISABETH CCO & EVP, CORPORATE STRATEGY

  • Officer
0 2018-02-16 0

DOW STEPHEN M

  • Director
307,190 2017-07-18 0

WHITAKER TIMOTHY M CHIEF MEDICAL OFFICER

  • Officer
0 2017-01-27 0

BRIDGER GARY

  • Director
0 2015-10-31 0

SRB ASSOCIATES IX L.P.

SEVIN ROSEN FUND IX L.P.

SEVIN ROSEN IX AFFILIATES FUND L.P.

  • AFFILIATEAFFILIATEAFFILIATE
No longer subject to file 2015-08-31 0

JAGGERS JOHN V

BAYLESS JON W

DOMENIK STEPHEN L

KIMZEY JACKIE R

MCLEAN DAVID J.

OXAAL JOHN T

SCHUELE ALAN R

STURIALE NICHOLAS G

  • AFFILIATEAFFILIATEAFFILIATEAFFILIATEAFFILIATEAFFILIATEAFFILIATEAFFILIATE
1,849,885 2015-08-11 0

NOVO A/S

  • 10% Owner
  • SEE REMARKS
3,201,183 2014-05-13 0

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

BONDERMAN DAVID

COULTER JAMES G

  • 10% Owner
2,488,533 2014-05-13 0

DAVIDSON AARON

  • Director
2,581,976 2014-05-13 0

H.I.G. VENTURE PARTNERS II, L.P.

H.I.G. VENTURES - ALDER, LLC

  • 10% Owner
516,395 2014-05-13 0

DELPHI MANAGEMENT PARTNERS VII, L.L.C.

DELPHI VENTURES VII L P

DELPHI BIOINVESTMENTS VII LP

PAKIANATHAN DEEPIKA

ROEDER DOUGLAS A

DOUGLASS DAVID L

BOCHNOWSKI JAMES J

  • Director
  • 10% Owner
2,838,532 2014-05-13 0

VENTURES WEST 8 LIMITED PARTNERSHIP

  • 10% Owner
3,469,528 2014-05-13 0

BISGAARD PETER

  • Director
0 2014-05-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments